Deep Medicine Acquisition... (DMAQ)
NASDAQ: DMAQ
· Real-Time Price · USD
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 10:00 PM
Deep Medicine Acquisition Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 5.39M | 21.86M | 6.24M | 3.87M | n/a | n/a | n/a | 90K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.73M | 7.24M | 1.92M | 1.3M | n/a | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K |
Gross Profit | 3.66M | 14.62M | 4.31M | 2.57M | n/a | -15K | -15K | 75K | -15K | -15K | -15K | -15K | -15K | -15K | -15K |
Operating Income | -1.23M | -1.21M | 872.28K | -785.04K | -359.95K | -270.35K | -261.56K | -859.97K | 645.77K | -1.84M | -515.66K | -179.4K | -152.6K | -93.77K | -31.5K |
Interest Income | 54.6K | 15.71K | 38.59K | 36.62K | n/a | 90.69K | n/a | n/a | n/a | 552.16K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -2.67M | -7.9M | -60.17K | -1.57M | -359.95K | -270.35K | -261.56K | -668.45K | 645.77K | -165.56K | -154.42K | -183.35K | -135.42K | -78.77K | -16.5K |
Net Income | -2.67M | -7.9M | -60.17K | -1.57M | -359.95K | -270.35K | -261.56K | -657.6K | 577.35K | 401.61K | -24.01K | -174.66K | -135.42K | -78.77K | -16.5K |
Selling & General & Admin | 2.73M | 5.65M | 1.58M | 2.02M | 368.89K | 327.15K | 328.18K | 549.21K | 400.36K | 717.72K | 269.83K | 177.03K | 137.6K | 78.77K | 16.5K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 445.94K | 2.65M | n/a | 40.23K | 46.6K | 33.88K | 58.92K | 200K | n/a | 15K | 15K | n/a | 15K | 15K | n/a |
Operating Expenses | 3.17M | 8.3M | 1.58M | 2.06M | 415.49K | 346.03K | 372.1K | 749.21K | 400.36K | 717.72K | 269.83K | 177.03K | 137.6K | 78.77K | 16.5K |
Interest Expense | -1.49M | -6.93M | -971.05K | -820.91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.63K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 4.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.9M | 15.54M | 3.5M | 3.36M | 415.49K | 361.03K | 372.1K | 764.21K | 415.36K | 717.72K | 269.83K | 177.03K | 137.6K | 78.77K | 16.5K |
Income Tax Expense | n/a | -110.53K | n/a | n/a | n/a | n/a | 110.53K | -10.85K | 68.42K | -567.16K | -130.41K | -8.69K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 11.63M | 11.63M | 13.38M | 13.28M | 4.36M | 4.39M | 4.61M | 2.31M | 15.39M | 16.43M | 16.43M | 8.74M | 12.35M | 16.43M | 16.43M |
Shares Outstanding (Diluted) | 11.63M | 11.63M | 13.38M | 13.28M | 4.36M | 4.39M | 4.61M | 10M | 15.39M | 16.43M | 16.43M | 8.74M | 12.35M | 16.43M | 16.43M |
EPS (Basic) | -0.09 | -679.35 | -4.5 | -0.12 | -0.08 | -0.06 | -0.06 | -0.28 | 0.04 | 0.02 | -0.00 | -0.02 | -0.01 | -0.00 | -0.00 |
EPS (Diluted) | -0.23 | -0.68 | -0.00 | -0.12 | -0.08 | -0.06 | -0.06 | -0.07 | 0.04 | 0.02 | -0.00 | -0.02 | -0.01 | -0.00 | -0.00 |
EBITDA | -1.23M | -14.6M | 872.28K | -785.04K | n/a | n/a | -482.63K | 2.09M | -1.48M | -717.72K | n/a | -170.72K | n/a | n/a | -16.5K |
EBIT | n/a | n/a | n/a | n/a | n/a | n/a | -261.56K | -859.97K | 645.77K | -1.27M | -385.25K | -185.72K | n/a | n/a | -31.5K |
Depreciation & Amortization | n/a | 351.34K | n/a | n/a | -39.59K | -90.69K | -221.07K | 1.42M | -2.12M | 567.16K | 130.41K | 8.69K | 17.18K | 15K | 15K |